Stock Events

Johnson & Johnson 

$146.97
25500
-$2.73-1.82% Friday 20:00

Statistics

Day High
149.81
Day Low
146.76
52W High
170.63
52W Low
141.57
Volume
8,973,755
Avg. Volume
7,253,704
Mkt Cap
353.71B
P/E Ratio
9.61
Dividend Yield
3.37%
Dividend
4.96

Upcoming

Dividends

3.37%Dividend Yield
10Y Growth
5.93%
5Y Growth
5.54%
3Y Growth
5.43%
1Y Growth
4.47%

Earnings

16JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Next
2.23
2.42
2.61
2.8
Expected EPS
2.718581
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JNJ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap163.65B
Pfizer competes directly with JNJ in the pharmaceuticals sector, offering a wide range of prescription drugs and vaccines.
Merck &
MRK
Mkt Cap327.97B
Merck operates in the pharmaceutical industry, directly competing with JNJ in areas such as vaccines and prescription medications.
Abbvie
ABBV
Mkt Cap277.35B
AbbVie, a research-based biopharmaceutical company, competes with JNJ in multiple therapeutic areas, including immunology and oncology.
Novartis
NVS
Mkt Cap220.15B
Novartis competes with JNJ in the healthcare sector, particularly in pharmaceuticals, offering drugs in areas like oncology and neurology.
Roche
RHHBY
Mkt Cap177.61B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, areas where JNJ is also a key player.
Bristol-Myers Squibb
BMY
Mkt Cap83.6B
Bristol Myers Squibb is a competitor in the pharmaceutical industry, offering prescription drugs in areas like cancer and cardiovascular diseases, similar to JNJ.
GSK
GSK
Mkt Cap93.51B
GlaxoSmithKline competes with JNJ in pharmaceuticals and consumer healthcare products, including vaccines and over-the-counter medicines.
Sanofi
SNY
Mkt Cap122.94B
Sanofi competes with JNJ in the pharmaceutical sector, particularly in areas like vaccines, rare diseases, and multiple sclerosis treatments.
AMGEN
AMGN
Mkt Cap164.06B
Amgen, a biopharmaceutical company, competes with JNJ in the development of innovative therapies, particularly in oncology and cardiology.
Abbott Laboratories
ABT
Mkt Cap180.83B
Abbott Laboratories competes with JNJ in the medical devices and diagnostics sectors, as well as in nutritional products and generic pharmaceuticals.

Analyst Ratings

177.13$Average Price Target
The highest estimate is $215.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy
63%
Hold
38%
Sell
0%

About

Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Show more...
CEO
Alex Gorsky
Employees
131900
Country
US
ISIN
US4781601046
WKN
000853260

Listings